Pharma & Biotech

First reported 3 hours ago - Updated 18 mins ago - 8 reports

BRIEF-BioAlliance Pharma shares rise 6.8 pct, agrees to buy Topotarget

8:02am BSTPARIS, April 16 (Reuters) - Bioalliance Pharma SA : * Shares rise 6.8 percent after announces Topotarget A/S takeover ... [Published Reuters UK - 4 mins ago]
First reported 16 hours ago - Updated 47 mins ago - 14 reports

GSK diabetes treatment gets FDA approval

Source: SMWGlaxoSmithKline has received US Food and Drug Administration approval for Tanzeum (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes.Tanzeum has been approved as an adjunct to diet and exercise ... [Published Telegraph - 47 mins ago]
First reported 19 hours ago - Updated 2 hours ago - 25 reports

Johnson & Johnson posts earnings of $1.54 a share vs. $1.48 estimate

Last month, Rep. Henry Waxman, a Democrat from California, and two other congressmen sent a letter[1] to Gilead Sciences[2] about the price of its recently approved medicine for hepatitis C, Sovaldi. The drug has drawn attention for its $84,000 price ... [Published DailyMe.Com - 2 hours ago]
First reported Apr 15 2014 - Updated 6 hours ago - 13 reports

4/16/2014: HtBusiness: Glenmark receives $5 mn payment from Sanofi

NEW DELHI: Glenmark Pharmaceuticals has received $5 million as a milestone payment from Sanofi for a new drug to treat chronic auto-immune disorders, taking total payments received till date to $55 million. ... [Published Hindustan Times - 6 hours ago]
First reported 20 hours ago - Updated 10 hours ago - 5 reports

Novartis marks 235 admin jobs for deletion amid companywide restructuring

$NVS ) is ticking off another 235 boxes on its job cuts list. The Swiss drugmaker plans to lay off 215 administrative and support staff in New Jersey by the end of June, and another 20 in similar ... ... [Published Big News Network - 10 hours ago]
Entities: Novartis AG, Layoffs
First reported 16 hours ago - Updated 10 hours ago - 8 reports

Teva Pharmaceutical Industries Limited Announces Launch Of Generic Lunesta?? Tablets In The United States

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Lunesta® (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Lunesta® Tablets, marketed by Sunovion Pharmaceuticals, ... [Published BioSpace - 10 hours ago]
First reported Apr 14 2014 - Updated 10 hours ago - 18 reports

GSK faces criminal investigation over bribery allegations in Poland

UK-based drug manufacturer GlaxoSmithKline (GSK) is facing allegations of bribing doctors to promote its asthma drug Seretide in Poland's Lodz region.The issue, reported by BBC on its Panorama programme, adds problems for GSK, which is already facing ... [Published Pharmaceutical Technology - 10 hours ago]
Entities: Bribery, Lodz, Poland, Allegation
First reported Apr 14 2014 - Updated 12 hours ago - 9 reports

A Brief Chat With the Mad Scientist Who Made Viagra Ice Cream

Charlie Francis is no stranger to unusual ice cream concoctions— he's the same guy who brought us a $225 scoop of luminescent jellyfish ice-cream just last year. Before you start licking his latest creation, though, better get yourself a prescription ... [Published Gizmodo - 12 hours ago]
First reported Apr 15 2014 - Updated 12 hours ago - 12 reports

This Forgotten Pharma Could Be a Hit for Your Portfolio

Within the world of Big Pharma,  Roche ( NASDAQOTH: RHHBY     ) offers a pretty compelling mix. Not only does Roche have one of the strongest oncology platforms today, it also offers one of the deepest pipelines. The company's non-oncology pipeline is ... [Published Motley Fool Discussion Boards - 12 hours ago]
First reported 16 hours ago - Updated 13 hours ago - 4 reports

Cerulean Pharma Closes Initial Public Offering

Cerulean Pharma Inc. (Nasdaq:CERU) today announced the closing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $7.00 per share, before underwriting discounts.Leerink Partners acted as sole book-running ... [Published Citybizlist - 13 hours ago]
First reported Apr 15 2014 - Updated 14 hours ago - 4 reports

Sanofi (France) Launches Probi Digestis® In Korea

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Probi (STO:PROB) Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, ... [Published BioSpace - 14 hours ago]
First reported Apr 14 2014 - Updated Apr 14 2014 - 50 reports

Polish prosecutors hit GlaxoSmithKline with third round of bribery charges

, a former GSK sales rep says the company was trading cash for prescriptions in the country in a wink-wink sort of way, by disguising the script incentives as speaking fees. And it's not just ... ... [Published Big News Network - Apr 14 2014]


...for every 27 Topotarget shares owned, implying approximately one-third ownership for Topotarget shareholders and two-thirds for BioAlliance Pharma. "The merger with Topotarget will strengthen and diversify our position in rare oncology diseases" BioAlliance Pharma Chief Executive Judith Greciet said in a statement...
"[More] women will crave for sweet and sugary foods compared to men because naturally women have low production of neurotransmitters in their bodies" Onyango says
...GSK senior vice-president and head of its global cardiovascular, metabolic and neurosciences franchise, Vlad Hogenhuis, said: "Many type 2 diabetes patients struggle to keep their blood sugar within the recommended levels. We are pleased that the approval of Tanzeum provides an effective new weekly GLP-1 treatment option for appropriate patients in the US."
...Sean Curtis, vice president, Respiratory and Immunology, Merck Research Laboratories. "This important milestone marks another opportunity for Merck to build on our respiratory heritage with allergy specialists."

More Content

All (40508) | News (40017) | Reports (1) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (224)
sort by: Date | Relevance
BRIEF-BioAlliance Pharma shares rise 6.8 pct, a... [Published Reuters UK - 5 mins ago]
Bosch Packaging Expands Capacity In Japan [Published Asian Scientist - 8 mins ago]
Aegerion Conducts Phase III Trial For Anti-Chol... [Published Asian Scientist - 8 mins ago]
Cancer drug company BioAlliance to buy Topotarget [Published Sharenet - 11 mins ago]
Glenmark Pharmaceuticals adds up to its portfolio [Published HDFC Securities - 18 mins ago]
Merck tapped as new school superintendent [Published Easley Progress - 20 mins ago]
Short Interest in Synergy Pharmaceuticals Incre... [Published American Banking News - Forex - 20 mins ago]
Short Interest in Galena Biopharma Expands By 8... [Published American Banking News - Forex - 20 mins ago]
Why Women Crave for Sugar More Than Men [Published - 21 mins ago]
Canada biotechnology market: $3.6bn industry in... [Published - 21 mins ago]
Corporate earnings: Coca-Cola, Intel, Yahoo, Jo... [Published Denver Post - 24 mins ago]
A Next Generation Biometric Market by Technolog... [Published - 26 mins ago]
Bioalliance Pharma SA and Topotarget A/S enter ... [Published Reuters UK - 32 mins ago]
AstraZeneca Pharma slips 2%, co defers delisting [Published India Everyday - 35 mins ago]
Reckitt Benckiser posts higher sales, says phar... [Published London South East - 45 mins ago]
Depomed settles Gralise patent dispute with Zyd... [Published PharmaBiz - 46 mins ago]
Letter: Independent pharmacies important to com... [Published Buffalo News - 48 mins ago]
Pursuing Pharma Manufacturing [Published Mergers & Acquisitions - 48 mins ago]
GSK diabetes treatment gets FDA approval [Published Telegraph - 48 mins ago]
Glenmark Pharma gains as its arm receives final... [Published Arihant Capital - 52 mins ago]
Buy USL but stay away from AstraZeneca: Edelwei... [Published - 52 mins ago]
Merck cleared to market grass allergy treatment [Published Chain Drug Review - 54 mins ago]
Maxwell House undergoes brand refresh [Published Chain Drug Review - 54 mins ago]
Albertsons, NAI pharmacies add Stayhealthy kiosks [Published Chain Drug Review - 54 mins ago]
RediClinic plans more clinics in Austin area [Published Chain Drug Review - 54 mins ago]
KISS, Broadway Nails make MTV Awards appearance [Published Chain Drug Review - 54 mins ago]
Samsung Galaxy S5 fingerprint scanner 'hacked',... [Published India Everyday - 57 mins ago]
Dosing initiated in Phase I/II clinical trial o... [Published NASDAQ OMX - 58 mins ago]
BioAlliance Pharma says agrees to buy Topotarget [Published Reuters - 1 hour ago]
API shares suspended from trading [Published Pharmacy News - 1 hour ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
From Sprint And TechStars To The FDA, A Look At... [Published TechCrunch - Oct 10 2013]
The health-care industry in the U.S. is broken, and considering the industry itself represents some 18 percent of the U.S. economy, it’s a sizable problem. While other sectors have begun to adapt, health care has managed to resist change — particularly ...

Press Releases

sort by: Date | Relevance
Using genomics to make personalized, safer medi... [Published PR Newswire - Feb 03 2014]
Endo Completes Acquisition of Specialty Generic... [Published PR Newswire - Feb 03 2014]
10 Reasons Why Biometric Exit May Advance in 2014 [Published PR Newswire - Feb 03 2014]
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
Novo Nordisk Promotes Eddie Williams to Senior ... [Published PR Newswire - Jan 30 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.